文献速递脊柱关节炎

基于44关节的银屑病关节炎疾病活动度指数(DAPSA44)的建立与验证

Development and validation of a Disease Activity index for PSoriatic Arthritis based on 44 joints (DAPSA44).
PubMed 文献 · Ann Rheum Dis · 2025-09-25

研究在脊柱关节炎(包括中轴型、外周型和银屑病关节炎)患者中,用44关节计数替代原DAPSA的66肿胀/68压痛关节计数,建立DAPSA44并验证其结构效度。共纳入4121例患者,推导队列得出肿胀和压痛关节的转换因子分别为1.34和1.30,验证队列显示DAPSA44与原DAPSA几乎完全一致(ICC 0.98,kappa 0.95),且在不同疾病活动状态间区分能力优秀(SMD>0.8)。结论支持在仅有简化关节计数时使用DAPSA44评估外周关节炎疾病活动度。

要点

  • 在4121例脊柱关节炎患者中建立并验证了基于44关节的DAPSA44。
  • DAPSA44与原DAPSA一致性几乎完美(ICC 0.98,kappa 0.95)。
  • DAPSA44在所有活动/不活动场景中区分能力优秀(SMD>0.8)。

核心结论

  • 研究结果支持DAPSA44作为与原DAPSA相当的工具,用于评估脊柱关节炎患者外周关节炎的疾病活动度,尤其在仅有简化关节计数可用时。

研究设计与样本

  • 研究纳入Assessment of SpondyloArthritis international Society-PerSpA研究中的中轴型脊柱关节炎、外周型脊柱关节炎和银屑病关节炎患者,按诊断和国家分层后以1:2随机分配至推导队列和验证队列。
  • 所有患者均有66肿胀关节计数/68压痛关节计数,并从中提取44肿胀关节计数/44压痛关节计数。
  • 推导队列采用混合效应线性回归模型计算将66肿胀关节计数/68压痛关节计数转换为44肿胀关节计数/44压痛关节计数的转换因子,以获得DAPSA44。
  • 验证队列通过原DAPSA与DAPSA44的连续性一致性(组内相关系数ICC)、疾病活动状态一致性(加权kappa)、Bland-Altman图、与原DAPSA和外部构念的Spearman相关性,以及基于患者总体评估(≥5/<5)联合肿胀关节计数(≥1/0或≥2/<2)分层后的已知组别区分度(标准化均数差SMD)评估DAPSA44的结构效度。

主要发现

  • 共纳入4121例患者,其中65%为中轴型脊柱关节炎,10%为外周型脊柱关节炎,25%为银屑病关节炎。
  • 推导队列(n=1364)中压痛关节计数和肿胀关节计数的转换因子分别为1.30和1.34。
  • 验证队列(n=2757)分析显示原DAPSA与DAPSA44之间几乎完全一致(ICC 0.98,kappa 0.95)。
  • DAPSA44与外部构念的Spearman相关系数落在相应原DAPSA系数的预设0.3宽范围内。
  • DAPSA44在所有活动/不活动疾病场景中均显示出优秀的区分能力(SMD>0.8)。

临床怎么用

  • 原文结论支持在仅有简化关节计数可用时,使用DAPSA44作为与原DAPSA相当的工具评估脊柱关节炎患者的外周关节炎疾病活动度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aims to develop a modified Disease Activity index for PSoriatic Arthritis (DAPSA) score using the 44-joint count instead of the 66 swollen/68 tender joint counts (SJC/TJC) in patients with spondyloarthritis (SpA) (axial SpA [axSpA], peripheral SpA [pSpA], and psoriatic arthritis [PsA]) and evaluate its construct validity. METHODS: Patients with axSpA, pSpA, and PsA included in the Assessment of SpondyloArthritis international Society-PerSpA (PERipheral involvement in SpondyloArthritis) study were randomly allocated 1:2 stratified for diagnosis and country into a derivation and validation cohort. For all patients, the 66SJC/68TJC were available, from which the SJC44/TJC44 were extracted. The derivation cohort was used to calculate the conversion factors for SJC66/TJC68 into SJC44/TJC44 to obtain the DAPSA44 using mixed-effects linear regression models. The validation cohort assessed the DAPSA44 construct validity through the agreement between continuous original-DAPSA/DAPSA44 (intraclass correlation coefficient [ICC]) and DAPSA disease activity states (weighted-kappa), Bland-Altman plot, Spearman correlations between original-DAPSA/DAPSA44 and external constructs, and discrimination between known groups (standardised mean differences [SMDs]) after stratifying patients into active/inactive based on a combination of patient global assessment (≥5/<5) and SJC (≥1/0 or ≥2/<2). RESULTS: A total of 4121 patients (65% axSpA, 10% pSpA, and 25% PsA) were included. Conversion factors from the derivation cohort (n = 1364) for TJC and SJC were 1.30 and 1.34, respectively. The validation cohort (n = 2757) analyses showed almost-perfect agreement between original-DAPSA and DAPSA44 (ICC 0.98, kappa 0.95). Spearman correlation coefficients between DAPSA44 and external constructs fell within the predefined 0.3-wide range of corresponding original-DAPSA coefficients. DAPSA44 demonstrated excellent discriminatory ability (SMD > 0.8) across all scenarios of active/inactive disease. CONCLUSIONS: These findings support the use of DAPSA44 as a comparable tool to the original DAPSA for assessing disease activity due to peripheral arthritis in SpA, especially in situations where only a reduced joint count is available.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Capelusnik D, Lopez-Medina C, van der Heijde D, et al. Development and validation of a Disease Activity index for PSoriatic Arthritis based on 44 joints (DAPSA44). Ann Rheum Dis. 2025. PMID: 41006175. doi:10.1016/j.ard.2025.08.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。